Fundz

BioVentrix

Mansfield, Massachusetts, United States · Medical, Other

BioVentrix is a privately held medical device company headquartered in San Ramon, CA, USA. Our mission is to improve and expand the treatment available for congestive heart failure (CHF) caused by ischemic cardiomyopathy, through the development of less invasive, catheter-based approaches.

Key facts

Headquarters
Mansfield, Massachusetts, United States
Employees
20
Industries
Medical, Other
Status
Private
Website
bioventrix.com
LinkedIn
Company page

Recent activity at BioVentrix

BioVentrix funding history

DateRoundAmount
Oct 2026Series A$1.2M
Apr 2026Series A$705K
Oct 2024Series A$125K
Mar 2024Series A$2.4M
Apr 2023Series A$48.5M

Leadership

  • Daniel Stack, Director of Quality
  • JAMES DILLON, Executive Officer, Director
  • RAYMOND COHEN, Director
  • GEORGE FAZIO, Director
  • STEVEN HEALY, Director
  • ANDREW HINSON, Director
  • MARK RAVICH, Director
  • DAVID RICHMOND, Director
  • RINDA SAMA, Director
  • MICHAEL TAGLICH, Director
  • KENNETH MILLER, Director
  • STEPHEN HEALY, Director

Verified email and direct lines for BioVentrix’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.

Employee benefit plans

BioVentrix files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.

BioVentrix in the news

Companies similar to BioVentrix

About BioVentrix: questions and answers

What does BioVentrix do?

BioVentrix is a privately held medical device company headquartered in San Ramon, CA, USA. Our mission is to improve and expand the treatment available for congestive heart failure (CHF) caused by ischemic cardiomyopathy, through the development of less invasive, catheter-based approaches.

Where is BioVentrix headquartered?

BioVentrix is headquartered in Mansfield, Massachusetts, United States.

How many employees does BioVentrix have?

BioVentrix has about 20 employees.

Has BioVentrix raised funding?

Yes. Fundz has recorded 5 funding events for BioVentrix. The most recent, Series A of $1.2M, was in Oct 2026.

What is the latest news on BioVentrix?

On Oct 08, 2026, BIOVENTRIX

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches BioVentrix across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.